Form 8-K - Current report:
SEC Accession No. 0001104659-25-017438
Filing Date
2025-02-26
Accepted
2025-02-26 16:13:13
Documents
41
Period of Report
2025-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm257513d1_8k.htm   iXBRL 8-K 25246
2 EXHIBIT 99.1 tm257513d1_ex99-1.htm EX-99.1 147577
3 EXHIBIT 99.2 tm257513d1_ex99-2.htm EX-99.2 45205
7 GRAPHIC tm257513d1_ex99-1img001.jpg GRAPHIC 13987
8 GRAPHIC tm257513d1_ex99-2img001.jpg GRAPHIC 157486
9 GRAPHIC tm257513d1_ex99-2img002.jpg GRAPHIC 312796
10 GRAPHIC tm257513d1_ex99-2img003.jpg GRAPHIC 83466
11 GRAPHIC tm257513d1_ex99-2img004.jpg GRAPHIC 171722
12 GRAPHIC tm257513d1_ex99-2img005.jpg GRAPHIC 191176
13 GRAPHIC tm257513d1_ex99-2img006.jpg GRAPHIC 78905
14 GRAPHIC tm257513d1_ex99-2img007.jpg GRAPHIC 115200
15 GRAPHIC tm257513d1_ex99-2img008.jpg GRAPHIC 100246
16 GRAPHIC tm257513d1_ex99-2img009.jpg GRAPHIC 159552
17 GRAPHIC tm257513d1_ex99-2img010.jpg GRAPHIC 90240
18 GRAPHIC tm257513d1_ex99-2img011.jpg GRAPHIC 118782
19 GRAPHIC tm257513d1_ex99-2img012.jpg GRAPHIC 138027
20 GRAPHIC tm257513d1_ex99-2img013.jpg GRAPHIC 96486
21 GRAPHIC tm257513d1_ex99-2img014.jpg GRAPHIC 113936
22 GRAPHIC tm257513d1_ex99-2img015.jpg GRAPHIC 156098
23 GRAPHIC tm257513d1_ex99-2img016.jpg GRAPHIC 161972
24 GRAPHIC tm257513d1_ex99-2img017.jpg GRAPHIC 37419
25 GRAPHIC tm257513d1_ex99-2img018.jpg GRAPHIC 137045
26 GRAPHIC tm257513d1_ex99-2img019.jpg GRAPHIC 98987
27 GRAPHIC tm257513d1_ex99-2img020.jpg GRAPHIC 108411
28 GRAPHIC tm257513d1_ex99-2img021.jpg GRAPHIC 135768
29 GRAPHIC tm257513d1_ex99-2img022.jpg GRAPHIC 179261
30 GRAPHIC tm257513d1_ex99-2img023.jpg GRAPHIC 124976
31 GRAPHIC tm257513d1_ex99-2img024.jpg GRAPHIC 209824
32 GRAPHIC tm257513d1_ex99-2img025.jpg GRAPHIC 93407
  Complete submission text file 0001104659-25-017438.txt   5090999

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tbph-20250226.xsd EX-101.SCH 3021
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20250226_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20250226_pre.xml EX-101.PRE 22363
43 EXTRACTED XBRL INSTANCE DOCUMENT tm257513d1_8k_htm.xml XML 3704
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 25670182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)